2023 Annual Meeting | C143 - Rapidly Progressive Dementia

Date Tuesday 04/25/23

Time 03:30 PM - 05:30 PM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Gregory S. Day, MD, MSc, FAAN

Topic(s) Aging, Dementia, and Behavioral Neurology

Learning Objectives Participants should learn the common causes and clinical features of rapidly progressive dementia; be able to apply sensitive and specific tests to accurately diagnose patients with specific causes of rapidly progressive dementia; and be able to recognize the clinical and paraclinical findings that suggest a potentially reversible cause of rapidly progressive dementia.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Quality Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
03:30 PM - 04:30 PM EST	Speaker	Rapidly Progressive Dementia: The Clinical Approach Gregory S. Day, MD, MSc, FAAN
04:30 PM - 05:00 PM EST	Speaker	Recognizing Reversible Causes of RPD Sarosh R. Irani, MD, PhD, FRCP, FEAN
05:00 PM - 05:30 PM EST	Speaker	RPD: Case-based Applications Gregory S. Day, MD, MSc, FAAN, Sarosh R. Irani, MD, PhD, FRCP, FEAN

Faculty Disclosures
Gregory S. Day, MD, MSc, FAAN	Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Parabon Nanolabs. The institution of Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from Chan Zuckerberg Initiative. The institution of Dr. Day has received research support from Alzheimer's Association. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Horizon Therapeutics. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with American Academy of Neurology. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing Education, Inc. Dr. Day has a non-compensated relationship as a Clinical Director with AntiNMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities.
Sarosh R. Irani, MD, PhD, FRCP, FEAN	Dr. Irani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB, Cerebral therapeutics, Roche and Janssen. Dr. Irani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain. Dr. Irani has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for LLPs. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care.